Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the blood loss in induced vaginal delivery by misoprostol and caesarians section with induction attempt.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maternidade Escola Assis Chateaubriand
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• Indication of early elective delivery by induction of labor (pre-eclampsia, HELLP syndrome, chronic hypertension, prolonged gestation, diabetes mellitus, gestational diabetes, heart disease, thyroid disease;

• pregnancy with living fetus;

• vertex cephalic presentation;

• estimated fetal weight by ultrasound > 2500g and <4000g;

• Amniotic fluid index (AFI)> 5 cm, except in cases of premature rupture of membranes in which AFI <5 cm would be allowed;

• cardiotocography (CTG) antepartum normal;

• Bishop Score less than or equal to 6;

• Determination of hemoglobin pre and post-partum.

Exclusion Criteria:

• Prior Cesarean section;

• previous uterine scar by myomectomy;

• Fetal presentation anomalous;

• Evidence of fetal abnormal (CTG, Ultrasound or Doppler);

• Fetal growth restriction;

• Gestation multiple;

• genital bleeding;

• tumors, malformations and / or ulceration in the region vulvoperineal and birth canal;

• No determination of hemoglobin pre-and post-partum;